UFP Technologies, Inc. Income (Loss) from Equity Method Investments
UFP Technologies, Inc. (UFPT) reported Income (Loss) from Equity Method Investments of -$10.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2026-08-06
- UFP Technologies, Inc. income (loss) from equity method investments for the quarter ending 2026-06-30 was $28.00K, a 50.88% decline year-over-year.
- UFP Technologies, Inc. income (loss) from equity method investments for the quarter ending 2026-03-31 was -$38.00K, a 192.68% decline year-over-year.
- UFP Technologies, Inc. income (loss) from equity method investments for the quarter ending 2025-12-31 was -$14.00K, a 115.73% decline year-over-year.
- UFP Technologies, Inc. income (loss) from equity method investments for the quarter ending 2025-09-30 was $35.00K.
- UFP Technologies, Inc. income (loss) from equity method investments for fiscal 2025 was $119.00K, a 33.71% increase from fiscal 2024.
- UFP Technologies, Inc. income (loss) from equity method investments for fiscal 2024 was $89.00K.
- UFP Technologies, Inc. income (loss) from equity method investments for fiscal 2023 was $0.00.
- UFP Technologies, Inc. income (loss) from equity method investments for fiscal 2022 was $0.00.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$10.00K 10-Q · filed 2026-08-06 | -$24.00K derived: sum of 3 quarters · filed 2026-08-06 | $11.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$38.00K 10-Q · filed 2026-05-08 | -$52.00K derived: sum of 2 quarters · filed 2026-05-08 | -$17.00K derived: sum of 3 quarters · filed 2026-05-08 | $40.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $21.00K derived: sum of 2 quarters · filed 2026-02-27 | $78.00K derived: sum of 3 quarters · filed 2026-08-06 | $119.00K 10-K · filed 2026-02-27 |
| 2025-09-30 | $35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $92.00K derived: sum of 2 quarters · filed 2026-08-06 | $133.00K 10-Q · filed 2025-11-07 | $222.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $98.00K 10-Q · filed 2026-08-06 | $187.00K derived: sum of 3 quarters · filed 2026-08-06 | $187.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $41.00K 10-Q · filed 2026-05-08 | $130.00K derived: sum of 2 quarters · filed 2026-05-08 | $130.00K derived: sum of 3 quarters · filed 2026-05-08 | $130.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $89.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $89.00K derived: sum of 2 quarters · filed 2026-02-27 | $89.00K derived: sum of 3 quarters · filed 2026-02-27 | $89.00K 10-K · filed 2026-02-27 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $0.00 derived: sum of 2 quarters · filed 2025-11-07 | $0.00 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $0.00 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-02-27 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |